Printer Friendly

Bristol-Myers Squibb Company names Dr Mike Burgess as SVP of Discovery Medicine and Clinical Pharmacology.

M2 PHARMA-January 18, 2013-Bristol-Myers Squibb Company names Dr Mike Burgess as SVP of Discovery Medicine and Clinical Pharmacology(C)2013 M2 COMMUNICATIONS

Biopharmaceutical company Bristol-Myers Squibb Company (NYSE:BMY) revealed on Thursday the appointment of Mike Burgess MD PhD as senior vice president of its Discovery Medicine and Clinical Pharmacology.

In the new role, Dr Burgess will report to the company's MB BChir FRCP senior vice president, Research, R&D, Francis Cuss, and will be a member of the Research Senior Leadership Team.

Most recently, Dr Burgess has served as interim head of Hoffman La-Roche's

Pharma Research and Early Development organisation, led its Oncology Discovery and Translational Area and was the head of Global Large Molecule Research. Previously, he was as a medical fellow at Eli Lilly and Company.

Currently, Dr Burgess is a member of the Royal College of Physicians and the Royal College of Pediatrics and Child Health.

((Comments on this story may be sent to info@m2.com))

COPYRIGHT 2013 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2013 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 Pharma
Date:Jan 18, 2013
Words:161
Previous Article:Exelis names Dr Pamela Drew as new president of its Information Systems business.
Next Article:pSivida Corp wins ILUVIEN's marketing approval in Spain for chronic diabetic macular edema.
Topics:

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters